Stryker Corporation (SYK): CEO sold, ~$5.87M

~$5.87M
Approx. value · 16K sh @ $369.75: 100K
Holds after · shares reported

Traded: Nov 7, 2024
Filed: Nov 8, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Nov 5, 2024Insider · 1 personInsiders: 8 sales (~$84.5M)
Nov 7, 2024 · this disclosureInsiderCEO sold ~$5.87M of SYK shares in the open market

What came next

Nov 7, 2024Insider · 1 personInsiders: 2 sales (~$15.3M)
Nov 15, 2024InsiderOfficer sold ~$201K of SYK shares in the open market
Jan 15, 2025Congress · 1 personMembers of Congress: 2 purchases
Jan 31, 2025Insider · 1 personInsiders: 7 sales (~$92.7M)
Feb 18, 2025InsiderDirector sold ~$942K of SYK shares in the open market
Feb 25, 2025FDARecall: Otopore Cylinder outer ear wound dressing, Firm Catalog Number 5400-020-000 and Forte Catalog Number 5400-020-000TL
Feb 25, 2025FDARecall: Nasopore FD fragmentable nasal dressing, Catalog Numbers 5400-020-108 and 5400-020-108ITL
Feb 25, 2025FDARecall: Otopore Square outer ear wound dressing, Firm Catalog Number 5400-020-100 and Forte Catalog Number 5400-020-100ITL
Feb 25, 2025FDARecall: Hemopore 8cm nasal/sinus temporary wound dressing, Catalog Numbers 5400-020-208 and 5400-020-208ITL (OUS)
Feb 25, 2025FDARecall: Hemopore 2PK nasal/sinus temporary wound dressing, Catalog Number 5400-222-208S
Feb 25, 2025FDARecall: Nasopore Standard 8cm fragmentable nasal dressing, Catalog Numbers 5400-010-008 and 5400-010-008ITL
Feb 25, 2025FDARecall: Nasopore 4cm Standard 2PK fragmentable nasal dressing, Catalog Number 5400-212-004S and Nasopore 4cm Firm 2PK Catalog Number 5400-222-004S
Feb 25, 2025FDARecall: Nasopore 8cm fragmentable nasal dressing, Firm Catalog Number 5400-020-008 and Forte Catalog Number 5400-020-008ITL
Feb 25, 2025FDARecall: Nasopore Standard 4cm fragmentable nasal dressing, Catalog Numbers 5400-010-004 and 5400-010-004ITL
Feb 25, 2025FDARecall: Nasopore Ex Firm 4cm fragmentable nasal dressing, Catalog Number 5400-030-004 and Nasopore Forte plus 4cm Catalog Number 5400-030-004ITL
Feb 25, 2025FDARecall: Nasopore Ex Firm 8cm fragmentable nasal dressing, Catalog Number 5400-030-008 and Nasopore Forte plus 8cm Catalog Number 5400-030-008ITL
Feb 28, 2025FDARecall: Monterey AL Implant Inserter; 14/16mm; Catalog 48019120.
Feb 28, 2025FDARecall: Monterey AL Implant Inserter; 10/12mm; Catalog 48019100.
Feb 28, 2025FDARecall: Monterey AL Implant Inserter; 18/20mm; Catalog 48019130.
Feb 28, 2025FDARecall: Monterey AL Implant Inserter; 22mm; Catalog 48019140.

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Stryker Corporation

For Stryker Corporation, OQRO holds 27 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 67 fund holdings reports (13F) and 3 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SYK page.

Other recent filings by Kevin Lobo, Chair and CEO

The full history of Kevin Lobo, Chair and CEO is on the profile page.

Other disclosures at Stryker Corporation

Everything OQRO holds on this company is on its SYK page.

Stryker Corporation (SYK)CEO sold ~$5.87M